The prices of Monosulfiram observed an uptrend in August after a decline in prices for two months as the demand from the domestic market revived. The inventory levels at the pharmaceutical sector pointed towards tightness due to increased seasonal end-user offtake. The feedstock was easily available in August that capped the market uptrend and supported Monosulfiram market stability. The Monosulfiram prices will maintain stability with nominal upward fluctuation over the upcoming period. The expected marginal increase is based on seasonal consumption patterns, inventory replenishment and absence of any disruptive public health developments.
